Free Trial

Cresset Asset Management LLC Acquires Shares of 1,391,514 Bain Capital Specialty Finance, Inc. (NYSE:BCSF)

Bain Capital Specialty Finance logo with Finance background

Cresset Asset Management LLC acquired a new position in shares of Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,391,514 shares of the company's stock, valued at approximately $25,006,000. Cresset Asset Management LLC owned 2.16% of Bain Capital Specialty Finance as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. CFO4Life Group LLC grew its position in shares of Bain Capital Specialty Finance by 2.5% during the 4th quarter. CFO4Life Group LLC now owns 31,499 shares of the company's stock worth $552,000 after buying an additional 769 shares during the period. Cooper Financial Group grew its holdings in Bain Capital Specialty Finance by 7.5% in the fourth quarter. Cooper Financial Group now owns 15,064 shares of the company's stock worth $264,000 after purchasing an additional 1,053 shares during the period. Prairiewood Capital LLC raised its holdings in shares of Bain Capital Specialty Finance by 8.6% during the fourth quarter. Prairiewood Capital LLC now owns 15,211 shares of the company's stock valued at $266,000 after purchasing an additional 1,201 shares during the period. Comerica Bank boosted its position in shares of Bain Capital Specialty Finance by 8.2% during the 4th quarter. Comerica Bank now owns 17,029 shares of the company's stock worth $298,000 after purchasing an additional 1,292 shares in the last quarter. Finally, Mascoma Wealth Management LLC acquired a new stake in shares of Bain Capital Specialty Finance in the 4th quarter valued at about $29,000.

Bain Capital Specialty Finance Stock Down 0.5 %

NYSE BCSF traded down $0.07 during trading hours on Friday, hitting $15.13. The company's stock had a trading volume of 208,569 shares, compared to its average volume of 244,744. The company has a market capitalization of $981.47 million, a PE ratio of 7.60 and a beta of 0.82. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 1.13. Bain Capital Specialty Finance, Inc. has a 52 week low of $13.20 and a 52 week high of $19.21. The company's 50-day simple moving average is $15.73 and its two-hundred day simple moving average is $16.85.

Bain Capital Specialty Finance (NYSE:BCSF - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. The company had revenue of $52.84 million for the quarter, compared to analysts' expectations of $71.00 million. Bain Capital Specialty Finance had a return on equity of 11.90% and a net margin of 43.62%. Research analysts anticipate that Bain Capital Specialty Finance, Inc. will post 2.06 EPS for the current fiscal year.

Bain Capital Specialty Finance Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Tuesday, December 16th will be issued a $0.03 dividend. The ex-dividend date is Tuesday, December 16th. This represents a $0.12 annualized dividend and a dividend yield of 0.79%. Bain Capital Specialty Finance's dividend payout ratio is currently 96.55%.

Insider Activity at Bain Capital Specialty Finance

In other Bain Capital Specialty Finance news, Director Clare Stack Richer purchased 1,530 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were acquired at an average cost of $16.43 per share, for a total transaction of $25,137.90. Following the completion of the acquisition, the director now owns 20,835 shares of the company's stock, valued at $342,319.05. The trade was a 7.93 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.59% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on BCSF. Wells Fargo & Company cut their price target on Bain Capital Specialty Finance from $19.00 to $16.00 and set an "overweight" rating on the stock in a report on Monday, April 28th. Keefe, Bruyette & Woods reduced their price target on shares of Bain Capital Specialty Finance from $18.00 to $17.00 and set a "market perform" rating for the company in a research report on Tuesday, April 8th.

Check Out Our Latest Analysis on Bain Capital Specialty Finance

Bain Capital Specialty Finance Profile

(Free Report)

Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.

Featured Stories

Institutional Ownership by Quarter for Bain Capital Specialty Finance (NYSE:BCSF)

Should You Invest $1,000 in Bain Capital Specialty Finance Right Now?

Before you consider Bain Capital Specialty Finance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bain Capital Specialty Finance wasn't on the list.

While Bain Capital Specialty Finance currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines